aTyr's lead drug, efzofitimod, just completed enrollment in its phase 3 EFZO-FIT trial for pulmonary sarcoidosis, with ...

Vertical Sees Strong Interest In Hybrid eVTOL is published in Advanced Air Mobility Report, an Aviation Week Intelligence Network (AWIN) Market Briefing and is included with your AWIN Premium ...